MRI-guided radiation to reduce dry mouth from head and neck cancer treatment
Part of Cancer clinical trials.
This trial tests if using an MRI to map saliva glands before radiation can help spare them, reducing dry mouth. It is for people with oropharynx cancer who will receive radiation with or without chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have oropharynx cancer (stage T0-4, N0-3, M0) that will be treated with radiation, possibly with chemotherapy.
- Be 18 years or older.
- Be able to have an MRI scan (no metal implants or claustrophobia issues).
- Have a performance status of 0, 1, or 2 (able to carry out daily activities with some help if needed).
- If you can become pregnant, agree to use highly effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how radiation therapy for head and neck cancer changes your sense of taste and saliva. It aims to better understand and manage these side effects.
This trial is testing a new way to use radiation therapy for head and neck cancer by also looking at the bacteria in your mouth and gut. The goal is to see if adjusting the treatment based on your bacteria can improve outcomes and reduce side effects.
This study looks at how radiation treatment for nasopharyngeal cancer affects the salivary glands, using special MRI scans to track changes over time. It might help find ways to reduce dry mouth and other side effects.
This study uses MRI scans to check for damage to the parotid gland (a saliva gland near the ear) caused by radiation therapy for nasopharyngeal cancer. The goal is to help doctors better protect this gland and improve quality of life during and after treatment.
This trial compares a new radiation technique designed to reduce dry mouth (xerostomia) with standard radiation for people with nasopharyngeal cancer. It aims to see if the new approach can protect saliva glands while still treating the cancer effectively.
This trial tests a new daily adaptive radiotherapy technique that aims to spare the submandibular salivary glands during head and neck cancer treatment. It may help reduce dry mouth after radiation.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.